Skip to main content

Table 4 Immunoexpression of the ZNF 281, stratified according to histopathological type, clinical stage, histological grade of ovarian tumors and menopausal status of the study patients (“other” corresponds to stage IB and higher clinical stages of ovarian tumors)

From: Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

ZNF 281

Group

Arithmetic mean

Standard deviation

Minimum

Lower quartile

Median

Upper quartile

Maximum

Mann-Whitney

U-test

Histopathological type

Borderline

3.13

2.36

0.00

2.00

2.50

4.00

8.00

H = 4.4292

p = 0.3510

Clarocellulare

3.70

2.71

0.00

3.00

3.50

4.00

8.00

Endometrioidales

3.13

2.36

0.00

2.00

2.50

4.00

8.00

Mucinosum

4.00

0.00

4.00

4.00

4.00

4.00

4.00

Serosum

4.23

1.83

2.00

4.00

4.00

4.00

8.00

Stage

IA

3.45

2.03

0.00

2.00

4.00

4.00

8.00

Z = 0.7566

p = 0.4493

Other

4.15

2.48

0.00

3.00

4.00

4.00

8.00

Grade

G1

4.38

1.51

3.00

4.00

4.00

4.00

8.00

Z = 1.3584

p = 0.1743

G2

3.62

2.30

0.00

2.00

4.00

4.00

8.00

Menopausal status

Postmenopausal

3.38

1.82

0.00

2.00

4.00

4.00

8.00

Z = 0.5567

p = 0.5777

Premenopausal

4.31

2.78

0.00

2.00

4.00

8.00

8.00